|Dose/Strength (ex. 1 mg or 1 ml)||250 mg|
|Packaging Size||42 Tabelts|
|Usage||Clinical, Hospital, Personal|
|Usage||Commercial, Clinical, Hospital, Personal|
Votrient (pazopanib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Votrient is used to treat advanced renal cell carcinoma (kidney cancer).
Votrient is indicated for the treatment of adult patients with selective subtypes of advanced Soft Tissue Sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.
Votrient 200 mg film-coated tablets
Capsule-shaped, white, film-coated tablet with GS UHL debossed on one side.